Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study.

OBJECTIVE: To describe oncologic and obstetric outcomes in patients diagnosed with cervical cancer during pregnancy who had a successful delivery after neoadjuvant chemotherapy. METHODS: A multicenter retrospective review was conducted in 12 institutions from six Latin American countries, between January 2007 and December 2018. Data collected included clinical characteristics, neoadjuvant chemotherapy agents, treatment, obstetric and oncologic outcomes. RESULTS: Thirty-three patients were included. Median age was 34 years (range 31-36). Twenty (60.6%) women were diagnosed at early stage (IB), and 13 (39.4%) with locally advanced stage (IIA-IIIB) according to FIGO 2009 classification. Carboplatin and paclitaxel was the most frequent combination used (60.6%). Partial and complete response rates were 27.3% and 9.1%, respectively. Median gestational age at delivery was 35 weeks (range 34-36). All patients had live births delivered by cesarean section. Obstetric pathology: pre-term labor, placenta percreta or intra-uterine growth restriction, was documented in seven patients (21.2%). Two (6.1%) neonates had low birth weight. Definitive treatment was primary chemo-radiation in 19 (57.6%) patients, radical hysterectomy in 11 (33.3%), abandoned radical hysterectomy with para-aortic lymphadenectomy and ovarian transposition in 1 patient (3.0%), and no further treatment in 2 (6.1%) patients. After a median follow-up of 16.3 months (range 2.0-36.9), 8 (26.7%) patients had recurrent disease. Of these, four (13.3%) died due to disease. CONCLUSION: Neoadjuvant chemotherapy may be offered to patients wishing to preserve an ongoing pregnancy in order to achieve fetal maturity. Long-term consequences of chemotherapy in the child are yet to be determined.

Emergency Embolization of Pelvic Vessels in Patients With Locally Advanced Cervical Cancer and Massive Vaginal Bleeding: A Case Series in a Latin American Oncological Center.

PURPOSE: Locally advanced cervical cancer may present with uncontrollable vaginal bleeding in up to 70% of cases. Pelvic vessel embolization has been used as an urgent maneuver for achieving fast hemostatic control. This report describes outcomes of selective pelvic vessel embolization in patients with severe bleeding due to a locally advanced cervical cancer. METHODS: In this retrospective study, technical aspects, clinical variables, and bleeding-related morbidity were described. The frequency of recurrent disease and the vital status at 1 year of follow-up were determined. Analysis was performed with statistical software R, version 3.6.2. The setting was Instituto Nacional de Cancerología- Bogotá, Colombia, between January 2009 and July 2017. RESULTS: A total of 47 patients were included. Median age was 44 years (range, 26-70 years). The pre-embolization median hemoglobin level was 7.9 g/dL (range, 5.0-11.3 g/dL). Blood transfusions were administered to 41 women (87.2%). Bleeding control was achieved in 95.7% of cases in the first 24 hours after the embolization. There were no major complications. In 17 cases (36.2%), minor complications were reported; the most common was pelvic pain. In 17.1% of cases, a second embolization was required. After 12 months of follow-up, 27.7% of patients were alive without disease, 44.7% were alive with disease, and 25.5% of them have died of cervical cancer progression. CONCLUSION: Selective pelvic vessel embolization is a useful alternative in patients with locally advanced cervical cancer and life-threatening bleeding. Its impact on recurrent disease and death due to oncologic cause is not clear.

Linfadenectomía paraaórtica extraperitoneal por laparoscopia como método clasificatorio en pacientes con diagnóstico de carcinoma de cérvix localmente avanzado: reporte de casos / Laparoscopic extraperitoneal para-aortic lymphadenectomy as a classification method in locally advanced cervical cancer: Report of a series of cases

Resumen Describimos la experiencia quirúrgica de diez pacientes sometidas a linfadenectomía paraaórtica extraperitoneal laparoscópica (LPEL) para clasificación en carcinoma de cérvix localmente avanzado (CCLA) y revisión de la literatura. Métodos: Búsqueda de literatura en MEDLINE y EMBASE usando palabras clave: "Uterine Cervical Neoplasms; Neoplasm Staging; Lymph Nodes; Lymph Node Excision; Laparoscopy; extraperitoneal''. Describimos la técnica quirúrgica para LPEL y resultados obtenidos en 10 pacientes intervenidas. Resultados: Diez pacientes con CCLA fueron sometidas a LPEL, rango de edad entre 29 y 65 años, sangrado operatorio entre 5 y 30cc, recuento ganglionar entre 2 y 11 ganglios; no complicaciones intraoperatorias y estancia hospitalaria entre uno y tres días. Conclusión: Es la primera experiencia reportada de LPEL para el CCLA en Colombia, siendo un procedimiento factible, seguro y útil para identificar compromiso paraaórtico adaptando el tratamiento.

Abstract A description is presented on the surgical experience of 10 patients who underwent laparoscopic extraperitoneal para-aortic lymphadenectomy (LEPL) in order to classify locally advanced cervical carcinoma (LACC), as well as a literature review. Methods: A literature search was performed in MEDLINE and EMBASE using the following keywords:''Uterine Cervical Cancer; Cancer Staging; Lymph Nodes; Lymph Node Excision; Laparoscopy; extraperitoneal''. The surgical technique for LEPL is described, as well as the outcomes of the 10 patients who underwent surgery. Results: A total of 10 patients, with ages between 29 and 65 years and with LACC underwent LPEL. There were surgical blood losses between 5 to 30 cc, a lymph node count between 2 and 11, no surgical complications, and a hospital stay of between 1 and 3 days. Conclusion: This is the first experience reported for LPEL for LACC in Colombia. It is a safe, feasible, and useful procedure to identify para-aortic involvement.